Printer Friendly PDF What is a Continuous Glucose Monitor (CGM)? A CGM is a wearable device that as the name implies, continually monitors your interstitial blood glucose (sugar) level providing real-time data to inform diabetes management. With expanded access,...
Printer Friendly PDF Common Fall & Winter Respiratory Illnesses Circulating respiratory viruses such as COVID-19, influenza (flu) and respiratory syncytial virus (RSV) aremore common in fall and winter, and can lead to significant illness and disease. COVID-19,...
Printer Friendly PDF Addressing Polypharmacy Polypharmacy, the concurrent use of multiple medications by a single individual, is a common and concerning issue among older adult patients. As we age, the risk for developing chronic health conditions becomes more common,...
Printer Friendly PDF FDA Approves First RSV Vaccines In May 2023, the Food and Drug Administration (FDA) approved the first vaccines for prevention of RSV associated lower respiratory tract disease (LRTD) in adults aged ≥60 years. RSVPreF3 (Arexvy, GSK) is a 1-dose...
Printer Friendly PDF Certain inhalation devices once opened or assembled and in use, must be used within a specified timeframe to avoid reduced stability and sterility, which can impact efficacy of treatment. Medications with shortened expiration dates, as specified...
Printer Friendly PDF About the Beers List The American Geriatric Society (AGS) Beers Criteria® for Potentially Inappropriate Medication (PIM) Use inOlder Adults, commonly called the Beers List, serves as a comprehensive list of medications that older people may want...
Printer Friendly PDF What is Tardive Dyskinesia? [1,2] Tardive Dyskinesia (TD) is an involuntary movement disorder characterized by uncontrollable, abnormal andrepetitive movements of the face, torso and /or other body parts. The physical symptoms of TD often can be...
Printer Friendly PDF The 2023 GOLD Report: Global Strategy for Prevention, Diagnosis, and Management of Chronic Obstructive Lung Disease On an annual basis the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) releases a strategy report covering all...
Printer Friendly PDF AHA/ACC/HFSA Guideline for the Management of Heart Failure (HF) [American Heart Association/American College of Cardiology/Heart Failure Society of America 2022 Joint Committee Clinical Practice Guideline Update] A jointly published update to the...
Printer Friendly PDF ADA Standards of Care in Diabetes Guidelines 2023 - What’s New? Type 2 DM Pharmacotherapy Selection Update and Management Considerations for Older Adults: Key updates related to T2DM pharmacotherapy from the 2023 ADA guideline include the...
CDC Recommendations: Printer Friendly PDF Per the CDC National Center for Immunization and Respiratory Diseases (NCIRD), the following practices should be considered when SARS-CoV-2 and Influenza viruses are found to be co-circulating based upon local public health...
![Product Focus: Aspruzyo Sprinkle® [Ranolazine]](https://www.hdrxservices.com/wp-content/uploads/2022/12/457-Prod-Focus-Aspruzyo-Sprinkle-Ranolazine-Dec-2022_post-2.png)
Printer Friendly PDF Description: ASPRUZYO Sprinkle contains ranolazine, an antianginal available as white to off-white coated extended-release granules filled in unit-dose sachets containing 500 mg or 1000 mg. Indications & Dosage: ASPRUZYO Sprinkle is indicated...